Glecaprevir Cv Pibrentasvir 12613-2625
Product NDC
12613-2625- Manufacturer
- Abbvie Deutschland Gmbh & Co Kg
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- November 29, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Glecaprevir | 100 mg/1 |
| Pibrentasvir | 40 mg/1 |
Packaging Options(1)
10300 TABLET, FILM COATED in 1 DRUM (12613-2625-9)